Why Chiron Real Estate Inc.’s (XRN) Stock Is Up 5.13%
As of Wednesday, August 12, Chiron Real Estate Inc.’s XRN share price has surged by 5.13%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Chiron is a real estate investment trust focused on investing in the future of healthcare. At Chiron we strive to deliver value at the intersection of care, capital and real estate. Chiron Real Estate Inc. was established in 2011 and was incorporated in Maryland.
Commentary & Analysis
Why Chiron Real Estate Inc.’s (XRN) Stock Is Up 5.58%
As of Wednesday, August 12, Chiron Real Estate Inc.’s XRN share price has surged by 5.58%, which has investors questioning if this is right time to sell.Michael Rose
Why Chiron Real Estate Inc.’s (XRN) Stock Is Up 6.07%
As of Friday, May 08, Chiron Real Estate Inc.’s XRN share price has surged by 6.07%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Chiron Real Estate Inc.’s (XRN) Stock Is Down 17.11%
As of Thursday, May 07, Chiron Real Estate Inc.’s XRN share price has dipped by 17.11%, which has investors questioning if this is right time to buy.Michael Rose
Financial Summary
| Share Statistics | XRN | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $489.3 | $4,394.7 | 36% |
|
| Shares Out (Mil) | 13.2 | 213.8 | 24% |
|
| Institutional Ownership | 97.4% | 98.8% | 74% |
|
| Float (Mil) | 12.2 | 178.2 | 22% |
|
| Beta | 1.13 | 0.77 | 67% |
|
| Avg Daily Volume (000s) | 77 | 1,385 | 33% |
|
| Price Change (52-week) |
(2.1%) | 89.7% | 44% |
|
| Growth | XRN | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 9.6% | 9.8% | 56% |
|
| Net Income (5yr) | (25.0%) | (8.6%) | 17% |
|
| EPS (5yr) | (1.6%) | (9.8%) | 29 |
|
| Dividends (5yr) | (3.6%) | 0.0% | 91% |
|
| Cash Flow (5yr) | (10.8%) | (15.0%) | 57% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | na | 1 | |
| Current EPS | ($0.850) | $2.850 | ($4.100) | |
| Month Ago EPS | ($0.255) | ($0.940) | ($1.530) | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.255) | ($0.940) | ($1.530) | |
| Year/Year Chg | (117.8%) | (414.6%) | (129.8%) | |
| Financials | XRN | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $153 | $793 | 29% |
|
| Net Income (TTM) (Mil) | $58 | $40 | 56% |
|
| EPS (TTM) | $3.691 | $0.700 | 81% |
|
| Operating Cash Flow (TTM) (Mil) | $75 | $238 | 49% |
|
| Net Cash Flow (TTM) (Mil) | $4 | ($1) | 51% |
|
| Long-Term Debt (Q1) (Mil) | $646 | $1,383 | 61% |
|
| Enterprise Value (Q1) (Mil) | $1,352 | $6,828 | 44% |
|
| Valuation | XRN | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.12 | 1.99 | 25% |
|
| P/E | 10.0 | 24.5 | 16% |
|
| Dividend Yield | 5.2% | 5.1% | 94% |
|
| PEG (5yr hist) | na | 1.7 | na |
|
| Ratios | XRN | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 100.0% | 61.2% | 96% |
|
| Net Margin | 37.8% | 7.9% | 93% |
|
| ROA | 4.3% | 1.6% | 68% |
|
| ROE | 13.4% | 3.8% | 67% |
|
| Liabilities to Assets | 50.1% | 49.4% | 42% |
|
| F-Score | 8 | 6 | 93% |
|
Passing Stock Screens
As of 9/4/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Neff Screen
Factors: Value, Growth
An approach using a stringent contrarian viewpoint—finding undervalued, out-of-favor stocks in the bargain basement that have an optimistic future.
| Performance Since Inception: | 14.7% |
| +/- S&P 500: | +7.2 |
